Trial
NCT00732147
Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
Amylin Pharmaceuticals, LLC.
Condition
Type 2 Diabetes
Intervention
Pramlintide acetate
Why stopped
Sponsor could not fund.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-22